Terry Dubrow, a plastic surgeon and TV personality based in Newport Beach, California, recommended that everyone takes a low daily dose, even if they dont need to lose weight
GS then multiplies these impacts by their projected number of GLP-1 users (30 million in baseline, up to 60 million) and expected effectiveness rates (70 percent in baseline, up to 90 percent)
Yes, you can change the time of day you take your injection without any safety concerns

Best Choices: Berries: strawberries, blueberries, raspberries, blackberries Apples (with skin for fiber) Pears Citrus: oranges, grapefruit, clementines Kiwi Peaches Plums Moderate Choices (smaller portions): Bananas Grapes Mango Pineapple Cherries Beverages Essential: Water (aim for 64+ oz daily) Add lemon & Celtic Sea Salt (helps flush the gut) Sparkling water (unsweetened) Herbal tea Green tea Black coffee (unsweetened) Optional: Bone broth (protein-rich, gut-healing) Electrolyte drinks (sugar-free) Protein shakes (low-sugar) Chobani Protein Shakes are sugar & lactose free Pantry Staples Seasonings & Flavor Enhancers: Celtic Sea salt and black pepper Garlic (fresh and powder) Onion powder Herbs: basil, oregano, thyme, rosemary Spices: cumin, paprika, turmeric, cinnamon Low-sodium soy sauce or coconut aminos Apple cider vinegar Balsamic vinegar Lemon and lime juice Hot sauce Mustard (Dijon, yellow) Cooking Essentials: Cooking spray (olive oil or avocado oil) Chicken or vegetable broth (low-sodium) Canned tomatoes (diced, crushed, sauce) Tomato paste Foods to Avoid or Limit on GLP-1 Medications These foods can worsen side effects or hinder your weight loss progress: High-Fat, Greasy Foods Fried foods (french fries, fried chicken, donuts) Fast food burgers and sandwiches Pizza (especially deep-dish or extra cheese) Creamy sauces and gravies Fatty cuts of meat (ribeye, bacon, sausage) Dairy (opt for greek yogurt or lactose free options) Why avoid: Can cause severe nausea, bloating, and digestive discomfort due to delayed gastric emptying

Altogether, our results support a key role of lipolysis in inducing dualAG-mediated M2-like immune signature and eWAT beiging although this relevant issue deserves further investigation in the setting of dualAG therapy
Well said, David Alderman